Share on StockTwits

Cytokinetics (NASDAQ:CYTK) will be posting its quarterly earnings results on Thursday, February 6th. Individual interested in listening to the company’s earnings conference call can do so using this link.

Cytokinetics (NASDAQ:CYTK) opened at 7.09 on Wednesday. Cytokinetics has a 1-year low of $5.76 and a 1-year high of $14.28. The stock’s 50-day moving average is $7.73 and its 200-day moving average is $8.11. The company’s market cap is $209.2 million.

Cytokinetics, Incorporated (NASDAQ:CYTK) is a biopharmaceutical company focused on the discovery and development of small molecule therapeutics that modulate muscle function for the potential treatment of serious diseases and medical conditions.

Get Analysts' Upgrades and Downgrades via Email - Stay on top of analysts' coverage with Analyst Ratings Network's FREE daily email newsletter that provides a concise list of analysts' upgrades and downgrades. Click here to register now.